Plasma-membrane calcium pumps [PMCAs (plasma-membrane Ca 2+ -ATPases)] expel Ca 2+ from eukaryotic cells to maintain overall Ca 2+ homoeostasis and to provide local control of intracellular Ca 2+ signalling.
PMCAs (plasma-membrane Ca
2+ -ATPases) are important parts of the toolkit for cellular Ca 2+ regulation Ca 2+ is a universal regulator of cellular processes ranging from fertilization to programmed cell death [1, 2] . Signalling by Ca 2+ requires an elaborate 'toolkit' of proteins to control the influx, efflux and buffering of Ca 2+ in and between different cellular compartments and among different cells [3] . High sensitivity and excellent signal-to-noise ratios are achieved by keeping cytosolic [Ca 2+ ] very low ( 100 nM) during the resting state. This is accomplished by Ca 2+ -buffering proteins and by integral membrane transport systems that can remove Ca 2+ from the cytosol even against large concentration gradients. Specialized transporters such as ion gradientdependent Na + /Ca 2+ exchangers and ATP-driven pumps are responsible for this 'uphill' transport of Ca 2+ across biological membranes [4] . The PMCAs are the major high-affinity Ca 2+ -handling system dedicated to the expulsion of Ca 2+ from the cytosol. Due to their ubiquitous expression and low transport capacity, they have long been assumed to be a housekeeping system responsible for setting and maintenance of the normally low cytosolic [Ca 2+ ] [5] . However, the discovery of multiple isoforms and alternative splice variants, and recent results on naturally occurring PMCA mutants and genetic-ally engineered PMCA 'knockout' mice, demonstrate that the PMCAs play distinct roles in tissue-and cell-specific dynamic Ca 2+ handling [6] [7] [8] . The range of functions for the PMCAs is therefore much wider than initially envisioned: PMCAs are not merely 'sump pumps' needed to remove 'excess' Ca 2+ , but instead are versatile tools needed to shape global and local Ca 2+ signals with high spatial and temporal resolution.
Structural diversity among PMCAs
The PMCAs are P-type ion-transporting ATPases (so named for the formation of an obligatory phosphorylated intermediate during the reaction cycle [9] ) and are members of the type IIB subfamily within the large superfamily of these ATPases [10] . In humans and other mammals, four major PMCA isoforms (PMCA1, 2, 3 and 4) are encoded by separate genes. In the human genome, these genes are localized on chromosomes 12q21.3, 3p25.3, Xq28 and 1q32.1. The encoded proteins range from 1115 to 1258 amino acid residues in length, with calculated molecular masses between ∼125 and 140 kDa. Although their global structures are very similar (with intracellular N-and C-terminal tails, ten membrane-spanning segments and two major cytosolic loops; see Figure 1 ), the average sequence identity between PMCA isoforms amounts to only approx. 80% [11] . The sequence differences are not evenly distributed; rather regions of high sequence divergence are interspersed with regions of high sequence conservation. The regions with high sequence variability (indicated by thick black lines in Figure 1 ) are responsible for the structural diversity of different PMCAs. Of note, the N-and C-terminal tails are among the least conserved regions in PMCAs. As shown in Figure 1 , the tail sequences are involved in numerous protein-protein interactions of functional importance, including binding of the major regulator CaM (calmodulin) to the C-terminal tail. The diversity of the PMCA family is further enhanced by alternative RNA splicing affecting two major 'hotspots' called sites A and C ( Figure 1 ). The combinatorial use of alternative splice options at these two sites results in the generation of over 20 PMCA variants [12] . These splice variants differ in the length of the first intracellular loop (splicing at site A) and in the C-terminal tail (site C splicing). Table 1 lists the major PMCA isoforms and splice variants in humans. Many of these PMCAs show developmental-, tissue-and cell-specific patterns of expression, suggesting their functional adaptation to the specific Ca 2+ handling needs of a given cell type [12] . Alternative splicing adds structural diversity to the PMCAs: splicing at site A alters the size of the first cytosolic loop by inserting up to 45 'extra' amino acids (in PMCA2w splice variants). Although no high-resolution structural information is as yet available for any PMCA, the variation in size of the second intracellular loop probably leads to significant local (and global?) structural differences. In support of this notion, the w-insert at splice site A directs PMCA2 to the apical membrane in polarized cells, whereas pumps with the shorter x-insert are targeted to the lateral membrane [13, 14] . Splicing at site C leads to even more dramatic structural changes resulting from a reading frame shift caused by differential exon usage. Consequently, splice variants 'a' and 'b' of each PMCA differ in the length and amino acid sequence of their C-terminal tail (see Figure 1 ). These differences underlie the divergent intramolecular interactions of the a-and b-splice variants with the catalytic domain of the PMCA (important for autoinhibition), and result in different interactions with external regulatory and signalling proteins. In turn, these structural differences lead to functional differences that enable different PMCA isoforms to fulfil tissue-and cell-specific roles in Ca 2+ handling.
Functional diversity among PMCAs
In the resting state, the PMCAs are autoinhibited by a mechanism that involves binding of their C-terminal tail to the two major intracellular loops. Activation requires binding of Ca 2+ -CaM to the C-terminal tail and a conformational change that displaces the autoinhibitory tail from the catalytic domain [15, 16] . PMCA activity is also affected by acidic phospholipids, phosphorylation of specific residues (both serine/threonine and tyrosine) in the C-terminal tail, partial proteolysis, and dimerization via the C-terminal tail [15, 17, 18] . Because PMCA isoforms and especially their C-terminal splice variants vary in sequence and, probably, in structure, their functional properties are also different. For example, the degree of autoinhibition (determined as basal activity in the absence of CaM) differs between a-and b-splice variants due to the different strength of interaction of their C-terminal tails with the catalytic domain. Differences in the binding kinetics and affinity for CaM lead to very different activation profiles of these splice variants, and this translates into different functional properties (reviewed in [6, 12] ).
Recent studies indicate that PMCA isoforms are differentially distributed in membrane subdomains such as sphingolipid-rich membrane 'rafts' [19, 20] . The differential partitioning of PMCA isoforms probably reflects structural differences, e.g. in the length and local arrangement of membrane-spanning sequences that favour specific lipid interactions. The lipid environment also impacts the functional properties of the PMCAs [21, 22] . The enrichment of distinct membrane domains in locales such as apical stereocilia of hair cells or presynaptic nerve terminals may lead to the local concentration of specific PMCAs and a concomitant effect on local Ca 2+ -handling properties. Alternative splicing at sites A and C influences the targeting and trafficking of the PMCAs (Figure 1) , underlining the importance of structural variations for the differential deployment and functional specialization of the pumps. The functional properties of individual PMCAs are relevant to how the pumps handle a cellular Ca 2+ signal. Studies on the kinetics of activation of different PMCAs reveal significant differences in their ability to respond to a sudden Ca 2+ rise and to decode the frequency of repetitive Ca 2+ spikes [23] . Comparing splice variants PMCA4a and 4b, which differ only in the length and sequence of the C-terminal tail, showed that the rate for CaM activation in PMCA4b is much slower (t1 / 2 ≈ 1 min at 0.5 µM Ca 2+ ) than in PMCA4a (t1 / 2 ≈ 20 s). The inactivation rate of PMCA4b is even slower (t1 / 2 ≈ 20 min), suggesting that this isoform is geared towards handling slow, tonic Ca 2+ changes [24] . On the other hand, the higher basal activity and faster activation by CaM allow PMCA4a to be more effective than PMCA4b in reducing an agonist-evoked intracellular Ca 2+ pulse. Because PMCAs detect changes in the sub-plasmalemmal Ca 2+ level, their 'reaction time' to Ca 2+ rises must be optimal for the desired outcome of Ca 2+ signalling. Detailed kinetic studies show that PMCA isoforms such as PMCA3f and PMCA2b expressed in cells with fast Ca 2+ responses (skeletal muscles and neurons) are generally 'fast', i.e. they are activated quickly by a rise in [Ca 2+ ] i (intracellular calcium concentration) [25] [26] [27] . The different time course of inactivation (by CaM release) also results in striking differences in the 'memory' of PMCA isoforms for their recent activation [23] . Thus, in cells with frequent Ca 2+ spikes, PMCA2b will remain 'pre-activated' and will respond almost immediately to the next Ca 2+ signal. The functional versatility of different PMCAs is enhanced by specific protein interactions (see Figure 1) . These interactions serve to connect specific PMCAs to particular signalling pathways, to recruit them to multiprotein complexes linked to the actin cytoskeleton, or to alter their regulatory properties [7] . Many of these protein interactions are isoformand/or splice-variant-specific. Accordingly, most of the interacting partners bind to the structurally diverse regions of the PMCAs, including the alternatively spliced C-tail and the N-terminal tail.
Conclusion: structural diversity underlies the functional versatility of PMCAs
PMCAs are essential components of the cellular toolkit to regulate and fine-tune cytosolic Ca 2+ concentrations. Work over the last 20 years has revealed a perplexing multitude of PMCA isoforms and alternative splice variants in mammalian tissues, raising questions about the specific role of different pumps in Ca 2+ handling. Studies on the regulation and kinetics of individual isoforms suggest that PMCAs are functionally diverse and optimized to participate in dynamic Ca 2+ handling according to tissue-and cell-specific demands. Different PMCAs help shape slow, tonic Ca 2+ signals in some cells and provide rapid, efficient Ca 2+ clearance in others. Underlying this functional diversity are structural differences among PMCAs. These structural differences are concentrated in the C-terminal alternatively spliced tail and in parts of specific intracellular regions of the pump involved in differential protein-protein interactions. Thus, while maintaining the overall structural framework necessary to function as membrane-bound high-affinity Ca 2+ -transporting ATPases, individual PMCA isoforms show significant local structural diversity in subdomains involved in regulation of activity, membrane targeting and signalling cross-talk. Future work will be directed at understanding the functional differences among PMCAs based on structural differences at the atomic resolution level.
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